How the U.S. can engage with the private sector to support women’s and family health

 

Rabin Martin has been a long-time advocate of the important role the private sector plays in addressing complex health issues to improve the lives of those across the globe.

As a member of the CSIS Task Force on Women’s and Family Health, Rabin Martin has encouraged expanding the role of the private sector and the importance of increased public-private partnerships in improving the health of women, children and adolescents. The Task Force comprises experts from government, academe, civil society and the private sector, and will be issuing its final report in late March with recommendations on how the new U.S. administration should launch a multi-sectoral investment in adolescent girls and young women in low-income countries.

In the lead up to this report, we developed papers on how the U.S. can engage with the private sector to support women’s and family health and sustain global commitments to life-saving immunization efforts.

We believe there is an opportunity to leverage the private sector’s business principles, expertise and past successes in improving health outcomes to drive future efforts and investments. Our key recommendations in this area include:

CSIS - private_sector (004)

 

 

Our key recommendations for sustaining global commitments to life-saving immunization efforts include:

CSIS - immunizations (004)

 

 

By fostering a multi-sectoral dialogue and encouraging public-private partnership, the U.S. can sustain American leadership in global health to save more lives and improve the well-being of women and families around the world.

 

Related:

The Private Sector’s Role in Ensuring Global Health Security

As the world faces increased globalization, climate change, and the emergence of health threats such as antimicrobial resistance, it is only a matter of time before the next pandemic strikes. The private sector is uniquely positioned to partner with countries to deliver innovative solutions to emerging global health threats.
read more

Reflections from BIO

From June 19-22, 2017, thousands of the world’s leading biopharmaceuticals descended on San Diego at BIO.  Rabin Martin was on the ground and brings you key insights from this year's conference on issues of access and commercialization in emerging markets, innovative financing models to support vaccine development, patient perspectives within value-based pricing schemes and biopharma’s response to the surge in antimicrobial resistance.
read more

The Private Sector Role in Public Health: Reflections on the New Global Architecture in Health

The Private Sector Role in Public Health: Reflections on the New Global Architecture in Health examines the convergence in perspectives between those who see business as a potential partner in improving the prospects for people living in low- and middle-income settings and those searching for new methods and new resources to address key unanswered questions about how to catalyze and sustain development gains in a world of growing constraints.
read more

Targeting Big Results in Maternal, Neonatal, and Child Health

Rabin Martin Vice President Sarah Hanck participated in a panel at the Center for Strategic International Studies (CSIS) to discuss ways to enhance U.S. engagement on Maternal and Child Health in sub-Saharan Africa. Sarah provided private sector perspective and maternal health expertise as one of the eight delegation members on a CSIS trip to Tanzania in February.
read more

Seminar Series on the Role of the Private Sector

Rabin Martin and Princeton University inaugurated the Princeton Seminar on Global Health with an event entitled, The Evolving Role of the Private Sector in Global Health. The Seminar gathers members of academe, the private sector, civil society and others to explore issues around improving global health quality, equity and access.
read more